APA

Samuel V. T., Choi C. S., Phillips T. G., Romanelli A. J., Geisler J. G., Bhanot S., McKay R., Monia B., Shutter J. R., Lindberg R. A., Shulman G. I. & Veniant M. M. (20060814). Targeting foxo1 in mice using antisense oligonucleotide improves hepatic and peripheral insulin action. : Diabetes.

Chicago

Samuel Varman T, Choi Cheol Soo, Phillips Trevor G, Romanelli Anthony J, Geisler John G, Bhanot Sanjay, McKay Robert, Monia Brett, Shutter John R, Lindberg Richard A, Shulman Gerald I and Veniant Murielle M. 20060814. Targeting foxo1 in mice using antisense oligonucleotide improves hepatic and peripheral insulin action. : Diabetes.

Harvard

Samuel V. T., Choi C. S., Phillips T. G., Romanelli A. J., Geisler J. G., Bhanot S., McKay R., Monia B., Shutter J. R., Lindberg R. A., Shulman G. I. and Veniant M. M. (20060814). Targeting foxo1 in mice using antisense oligonucleotide improves hepatic and peripheral insulin action. : Diabetes.

MLA

Samuel Varman T, Choi Cheol Soo, Phillips Trevor G, Romanelli Anthony J, Geisler John G, Bhanot Sanjay, McKay Robert, Monia Brett, Shutter John R, Lindberg Richard A, Shulman Gerald I and Veniant Murielle M. Targeting foxo1 in mice using antisense oligonucleotide improves hepatic and peripheral insulin action. : Diabetes. 20060814.